An integrated biore fi nery concept for conversion of sugar beet pulp into value-added chemicals and pharmaceutical intermediates
An integrated biore fi nery concept for conversion of sugar beet pulp into value-added chemicals and pharmaceutical intermediates
复制标题
将甜菜浆转化为增值化学品和医药中间体的综合生物炼制概念
DOI:
--
复制
发表时间:
--
期刊:
影响因子:
--
通讯作者:
G. Lye
中科院分区:
文献类型:
--
作者:
Max Cárdenas‐Fernández;Maria Bawn;Charlotte Hamley;Penumathsa K. V. Bharat;Fabiana Subrizi;N. Suhaili;David P. Ward;Sarah Bourdin;P. Dalby;H. Hailes;P. Hewitson;S. Ignatova;C. Kontoravdi;D. Leak;N. Shah;T. Sheppard;J. Warda;G. Lye
Over 8 million tonnes of sugar beet are grown annually in the UK. Sugar beet pulp (SBP) is the main by-product of sugar beet processing which is currently dried and sold as a low value animal feed. SBP is a rich source of carbohydrates, mainly in the form of cellulose and pectin, including D -glucose (Glu), L -arabinose (Ara) and D -galacturonic acid (GalAc). This work describes the technical feasibility of an integrated biore fi nery concept for the fractionation of SBP and conversion of these monosaccharides into value-added products. SBP fractionation is initially carried out by steam explosion under mild conditions to yield soluble pectin and insoluble cellulose fractions. The cellulose is readily hydrolysed by cellulases to release Glu that can then be fermented by a commercial yeast strain to produce bioethanol at a high yield. The pectin fraction can be either fully hydrolysed, using physico-chemical methods, or selectively hydrolysed, using cloned arabinases and galacturonases, to yield Ara-rich and GalAc-rich streams. These monomers can be separated using either Centrifugal Partition Chromatography (CPC) or ultra fi ltration into streams suitable for subsequent enzymatic upgrading. experience with transketolase (TK) and transaminase (TAm) enzymes, the conversion of Ara and GalAc into higher value products was explored. In particular the conversion of Ara into L - gluco -heptulose (GluHep), that has potential therapeutic applications in hypoglycaemia and cancer, using a mutant TK is described. Preliminary studies with TAm also suggest GluHep can be selectively aminated to the corresponding chiral aminopolyol. The current work is addressing the upgrading of the remaining SBP monomer, GalAc, and the modelling of the biore fi nery concept to enable economic and Life Cycle Analysis (LCA). data points represent actual experimental design points. 11 SE pretreatments over various times and operating pressures were performed using a central composite design. SE experiments were carried out in a stirred Parr pressure reactor (1 L capacity, Boston Instruments) with 50 g of whole and washed SBP at the speci fi ed pressure and time with agitation fi xed at 150 rpm. (Ara) L -arabinose, (Gal) D galactose and (GA) D -galacturonic acid. Experiments were performed using a 250 mL semi-preparative CPC column (Kromaton), using an ethanol : ammonium sulphate (300 g L (cid:4) 1 ) (0.8 : 1.8 v/v) phase system at 1000 rpm in ascending mode, with a mobile phase fl ow rate of 8 mL min (cid:4) 1 . Stationary phase retention was 50%. the stereoselective amination of the remaining GalAc fraction using transaminases including the C. violaceum u -TAm. Initial studies have suggested that this enzyme can convert GalAc into 6-amino-2,3,4,5-tetrahydroxyhexanoic acid which can be used for the synthesis of biopolymers such as polyhydroxypolyamides 34 and as a precursor for potent antiviral polyhydroxyazepanes. 35 Three of the enzymes used in this study (AF, TK and TAm) have been expressed in E. coli which can yield high speci c enzyme activities when grown on diluted sugar beet vinasse. Future studies will address some of the major engineering challenges associated with the integrated SBP biore nery concept. These are summarised